Part,  Chapter, Paragraph

  1    I,     2. 10.  4(13)|           Fact sheet N 275Revised 14 November 2006~
  2    I,     2. 10.  4(15)|           Fact sheet N 275Revised 14 November 2006~
  3    I,     3.  3        |             of the population aged 0-14, 15-64 and 65+. They picture
  4    I,     3.  3        |            of EU27 population aged 0-14 and 65 or more from 1950
  5    I,     3.  3        |              be noted:~ ~Children (0-14 years). Bulgaria, Italy,
  6    I,     3.  3        |              not change much (Figure 14). Poland, Slovakia, Bulgaria,
  7   II,     4.  1        |             9.1 years to 23.6 years (14.5 years gap) for men and
  8   II,     4.  1        |             At 50 the HLY gaps reach 14.5 years for men and 13.7
  9   II,     4.  2        |              causes of death’ (cause 14 in table 3) across European
 10   II,     4.  3        |           Journal of Women and Aging 14(1-2): 119-133.~ ~Robine,
 11   II,     4.  3        |            of Public Health 13(3): 6-14.~ ~Robine, J.-M., C. Jagger,
 12   II,     4.  3        |             Public Health 2003; 13:6-14.~ ~Robine, J.-M., C. Jagger,
 13   II,     5.  2.  3    |           diseases (codes ICD-9: 410-14) - Age-standardized (standard
 14   II,     5.  2.  3    |            diseases (codes ICD-9 410-14) Men aged 35-74 years~ ~
 15   II,     5.  2.  3    |            diseases (codes ICD-9 410-14) Women aged 35-74 years~ ~
 16   II,     5.  2.  6    |          from 90,056 participants in 14 randomised trials of statins.
 17   II,     5.  2.  6    |          Elderly Study). J Hypertens 14: 1159-1166.~Lewington S,
 18   II,     5.  3.  6    |               Europe-wide trends for 14 childhood cancers were also
 19   II,     5.  3.  7    |        further details see Chapter 4.14.~ ~
 20   II,     5.  3.  8    |        Europe we can estimate nearly 14 million of all cancer prevalent
 21   II,     5.  3.  9    |             third version. Ann Oncol 14(7):973-1005.~ ~Coleman MP,
 22   II,     5.  3.  9    |              20th century. Ann Oncol 14 (suppl 5):v128-v149.~ ~ESMO (
 23   II,     5.  3.  9    |            registry areas. Ann Oncol 14:v28-v40.~ ~Micheli A, Berrino
 24   II,     5.  3.  9    |            and commentary. Ann Oncol 14 (suppl 5):v61-v118.~ ~Stewart
 25   II,     5.  4.  2    |       population with a BMI 30 kg/m2~14~ ~HES/HIS Registry~II Epidemiology
 26   II,     5.  4.  2    |             age/100,000 population 014 years~12~HES/HIS Registry~
 27   II,     5.  4.  2    |            10: Diabetes mellitus E10–14; HES: Health Examination
 28   II,     5.  4.  2    |              diabetes in children (0-14 year), with type 1 and 2
 29   II,     5.  4.  2    |              tested, with HbA1c>7.5%~14~Percent of diabetic subjects
 30   II,     5.  4.  2    |        profile in the last 12 months~14~Percent of diabetic subjects
 31   II,     5.  4.  2    |           total cholesterol>5 mmol/l~14~Percent of diabetic subjects
 32   II,     5.  4.  2    |        measurement in last 12 months~14~Percent of of diabetic subjects
 33   II,     5.  4.  2    |             subjects who are smoking~14~Percent of diabetic subjects
 34   II,     5.  4.  3    |              diabetes in children (0-14 year). Standardised incidence
 35   II,     5.  4.  3    |           and 2.4% (1.0-3.8%) for 10-14 years (Green, 2001).~Prevalence
 36   II,     5.  4.  3    |              in crude percentages of 14% (Ireland) to 68% (Cyprus)
 37   II,     5.  4.  3    |               ranging between 1% and 14%.~Indicator on timely laser
 38   II,     5.  4.  4    |               with a median value of 14%. The problem increases
 39   II,     5.  4.  6    |      According to the IDF, among the 14 countries with no plan,
 40   II,     5.  4.  8    |        Nutrition and Metabolism 2001;14(2), 100-103.~Carinci M,
 41   II,     5.  4.  8    |            Proc Natl Acad Sci U S A. 14;104(33):13225-31~TRIG p (
 42   II,     5.  5.  1    |             citizens, 45 000 men and 14 000 women committed suicide
 43   II,     5.  5.  1    |             any anxiety disorder was 14%. Table 5.5.1.1 presents
 44   II,     5.  5.  1    |             respectively.~ ~In the 0-14 age group (Table 5.5.1.8)
 45   II,     5.  5.  1    |            suicide in the world with 14 per 100 000 (WHO statistics).~ ~
 46   II,     5.  5.  1    |        Epidemiol Psichiatr Soc 17(1):14-9.~ ~S H et al. (2006).
 47   II,     5.  5.  1    |             Qual Life Res 15(8):1403-14.~ ~Schmidtke A., Bille-Brahe
 48   II,     5.  5.  2    |             Ferri et al analysed the 14 WHO worlds regions but for
 49   II,     5.  5.  3    |         categories are observed 0 to 14 years and 15 to 19 years.
 50   II,     5.  5.  3    |            separately in age group 0-14).~Finland~ ~X~ ~France~ ~
 51   II,     5.  5.  3    |              incidence rate among 10-14-year-old females has risen
 52   II,     5.  5.  3    |          article online, accessed on 14 February 2008).~The Cleveland
 53   II,     5.  5.  3    |         follows:~Mini survey Finland 14.3%~NEMESIS Netherlands 53.
 54   II,     5.  5.  3    |                    last accessed Dec 14, 2007.~Wrigley S, Jackson
 55   II,     5.  5.  3    |           children born in 1994 from 14 states. A total of 407,578
 56   II,     5.  5.  3    |          common etiological factors (14-21%) followed by trauma (
 57   II,     5.  5.  3    |        Tidman et al., 2003 (*)~+ = 5-14 years - = 6-12 years MR =
 58   II,     5.  5.  3    |   Pediatricians ~ = 6-16 years Ø = 6-14 years GP = General practitioners
 59   II,     5.  5.  3    |         policies~Prevalent cohort~32~14.6~2.2~Svensson and Astrand,
 60   II,     5.  5.  3    |      epilepsy during the first 10 to 14 years of disease. Generalised
 61   II,     5.  5.  3    |             up prospectively over 11-14 years. J Neurol Neurosurg
 62   II,     5.  5.  3    |           greater proportion) costs14 300 per year, €31 200 per
 63   II,     5.  5.  3    |               but accounted for only 14% of the variation between
 64   II,     5.  5.  3    |             at: htt rg Accessed June 14 2005.~Granieri E, Malagú
 65   II,     5.  5.  3    |             in: Mult Scler. 2008 May;14(4):574.~Sumelahti ML, Tienari
 66   II,     5.  5.  3    |           specific foods. Mov Disord 14(1):21-27.~Andlin-Sobocki
 67   II,     5.  5.  3    |          analysis. Pharmacoeconomics 14(3):299-312.~Dorsey ER, Constantinescu
 68   II,     5.  5.  3    |            Aragon, Spain. Mov Disord 14(4):596-604.~EuroPa Consortium (
 69   II,     5.  5.  3    |     southeastern Sweden. Mov Disord. 14:28-37.~ ~Findley L, Aujla
 70   II,     5.  6.  4    |          with sick leave longer than 14 days due to musculoskeletal
 71   II,     5.  6.  6    |           for Europe, Copenhagen, 11-14 September 2006. Available
 72   II,     5.  7.  3    |              ESRD in children aged 0-14 was 7.1 patients pmarp (
 73   II,     5.  7.  3    |           prevalence of RRT in the 0-14 years age group was 43 per
 74   II,     5.  7.  3    |              stage 1-5 CKD rose from 14.5% (NHANES III) to 16.8% (
 75   II,     5.  7.  3    |              65+ age group. In the 0-14 age group, however, the
 76   II,     5.  7.  3    |              72% for patients aged 0-14, 15-64 and over 65 years
 77   II,     5.  7.  5    |             approach to the problem {14 National Kidney Foundation,
 78   II,     5.  7.  7    |               JAMA 2003;290(23):3101-14.~Chadban SJ, Briganti EM,
 79   II,     5.  7.  7    |         study. J Am Soc Nephrol 2003;14(7 Suppl 2):S131-S138.~Chen
 80   II,     5.  7.  7    |              Am Soc Nephrol 2003 Oct;14(10):2573-80.~Loucks EB,
 81   II,     5.  8.  2    |            among asthmatic patients, 14% in Po Delta and 11% in
 82   II,     5.  8.  2    |       emphysema, 31% in Po Delta and 14% in Pisa also reported asthma (
 83   II,     5.  8.  3    |        disease in 40-69 year olds to 14.4% (6.3% COPD) (Murtagh
 84   II,     5.  8.  7    |         Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer L, Lamprecht
 85   II,     5.  9.  2    |             304 679 children aged 1314 years from 106 centres in
 86   II,     5.  9.  2    |             years from 29 centres in 14 countries (mostly European).
 87   II,     5.  9.  3    |          Figure 5.9.3. Asthma by age 14 years in ECHRS and ISAAC
 88   II,     5.  9.  3    |              prevalence in children, 14.7% in adolescents, while
 89   II,     5.  9.  3    |              16.9% in children of 13.14 years of age), Romania (
 90   II,     5.  9.  3    |              while adolescents 13 to 14 years old presented a 37.
 91   II,     5.  9.  3    |             Romania 15%, Switzerland 14.2% in adults and 17% in
 92   II,     5.  9.  3    |             age-group than in the 1314 years of age-group: for
 93   II,     5.  9.  3    |              no changes); for the 1314 years of age-group, 11 of
 94   II,     5.  9.  3    |         emergency room treatment was 14-18%. Nevertheless, in different
 95   II,     5.  9.  4    |            1450 children aged 13- to 14- and living in Brescia,
 96   II,     5.  9.  4    |         clinical asthma among 13- to 14-yr-old adolescents seem
 97   II,     5.  9.  7    |              fever, and eczema in 12-14 year olds in the British
 98   II,     5. 10.  7    |              310, 28.11.2007, pp. 1114.~ ~European Food Safety
 99   II,     5. 11.  3    |       General Internal Medicine 1999;14(6):379385.~B Larsson-Stymne,
100   II,     5. 11.  3    |              per 100 000 for SCC and 14 per 100 000 for melanoma (
101   II,     5. 11.  7    |             Prev Soc Med 1976;30:10714.~ ~Ryan TJ (1991): Disability
102   II,     5. 12.  7    |         liver cirrhosis mortality in 14 European countries. Addiction
103   II,     5. 14        |                                    5.14 Dental and oral diseases~ ~
104   II,     5. 14.  1    |                                    5.14.1 Introduction~ ~Oral disease
105   II,     5. 14.  2    |                                    5.14.2 Data sources~ ~ ~Data
106   II,     5. 14.  3    |                                    5.14.3 Data description and analysis~ ~
107   II,     5. 14.  3    |            severity (DMFT). (Table 5.14.1). For instance, the actual
108   II,     5. 14.  3    |              is 1.0 DMF-T.~ ~Table 5.14.1. Dental Health in 12 year-old
109   II,     5. 14.  3    |             loss in Europe (Figure 5.14.1). Edentulous prevalence
110   II,     5. 14.  3    |             the future.~ ~ ~Figure 5.14.1. Edentulous people aged
111   II,     5. 14.  3    |              15% of adults (Figure 5.14.2). According to the results
112   II,     5. 14.  3    |            and 4% severe.~ ~Figure 5.14.2. Adults aged 35-44 with
113   II,     5. 14.  3    |            health services. Figure 5.14.3 illustrates the difference
114   II,     5. 14.  3    |             the age of12.~ ~Figure 5.14.3. Children aged 12 with
115   II,     5. 14.  4    |                                    5.14.4. Risk factors~ ~The caries
116   II,     5. 14.  5    |                                    5.14.5. Control tools and policies~ ~
117   II,     5. 14.  6    |                                    5.14.6. Policies~ ~At the 60th
118   II,     5. 14.  7    |                                    5.14.7. Future developments~ ~
119   II,     5. 14.  8    |                                    5.14.8. References~ ~Bourgeois
120   II,     6.  3.  4    |       observed among children aged 014 years. In all, the peak
121   II,     6.  3.  4    |        overall, while children under 14 represented 4%. Mean age
122   II,     6.  3.  5    |            by the under-4 age group (14.1 per 100 000), while the
123   II,     6.  3.  5    |           the youngest age groups (014 years).~ ~In 2005, a total
124   II,     6.  3.  6    |          yersiniosis with Lithuania (14.63 per 100 000) followed
125   II,     6.  3.  6    | toxoplasmosis cases were reported by 14 countries, with Lithuania (
126   II,     6.  3.  6    |           000), followed by Iceland (14.65 per 100 000) reported
127   II,     6.  3.  6    |            age groups are children 514 years of age and adults
128   II,     6.  3.  6    |             a mean survival of about 14 months. The main suspected
129   II,     6.  3.  7    |            65%), followed by Greece (14%). In 2005, 21 countries
130   II,     7.  3.  4    |              injury sector (Figure 7.14).~ ~Figure 7.14. Non fatal (
131   II,     7.  3.  4    |             Figure 7.14).~ ~Figure 7.14. Non fatal (hospital treated
132   II,     7.  4.  4    |             activities (see Figure 7.14).This means that an annual
133   II,     8.  1.  3    |   considerable limitations and about 14% of those limited to some
134   II,     8.  2.  1    |              across Europe. A set of 14 Country Reports gives considerable
135   II,     8.  2.  1    |            followed up to the age of 14 in Northern Finland. It
136   II,     8.  2.  1    |         intellectual disabilities in 14 participating countries (
137   II,     8.  2.  1    |        surveyed current practices in 14 European countries and made
138   II,     9.  1.  1    |           Paediatr Perinat Epidemiol 14(3):194-210.~ ~Kramer MS,
139   II,     9.  1.  1    |               Health Stat Q 2004(24):14-22.~Olausson PM, Cnattingius
140   II,     9.  1.  2    |          Congenital Malformations in 14 Regions of Europe”, Prenatal
141   II,     9.  2.  2    |            produced for those aged 0-14 years inclusive, or those
142   II,     9.  2.  2    |            group. Using a cut-off at 14 years excludes an important
143   II,     9.  2.  2    |         generally being those aged 0-14 years (from birth to early
144   II,     9.  2.  3    |              2), and accidents for 5-14 year olds (see Chapter 7).~ ~
145   II,     9.  2.  3    |            cancer in children aged 0-14 in selected EUGLOREH Countries –
146   II,     9.  2.  3    |            cancer in children aged 0-14 in selected EUGLOREH Countries –
147   II,     9.  2.  3    |       symptoms” for children aged 13-14 for those countries which
148   II,     9.  2.  3    |           clinical asthma2 in 13- to 14-year-old children as high
149   II,     9.  2.  3    |               15.3% for England, and 14.6% in Ireland, which rank
150   II,     9.  2.  3    |             death in children aged 1-14 in Europe. Over 40% of 11–
151   II,     9.  2.  3(2) |            12-month period in 13- to 14-year-old children) was used
152   II,     9.  2.  7    |        Available at:~htt ml accessed 14.01.07~ ~UNICEF (2002): Young
153   II,     9.  3.  1    |             in Psychiatric Treatment 14: 256-262~ ~Braun, M., Wassner,
154   II,     9.  3.  2    |      Paediatr Perinat Epidemiol 2000;14(3):194-210.~ ~Langer B,
155   II,     9.  3.  2    |               Health Stat Q 2004(24):14-22.~ ~Marret S, Ancel PY,
156   II,     9.  3.  3    |        sexuality in the age group of 14 to 17 year olds and their
157   II,     9.  3.  3    |             Representative survey of 14 to 17- year-olds and their
158   II,     9.  4.  3    |             by the population aged 0-14 years [per 100]) shows that
159   II,     9.  5.  4    |             Reference A6-0199/2005 : 14/09/2006Promoting health
160   II,     9.  5.  6    |                Health selection in a 14-year follow-up study - a
161  III,    10.  1.  3    |              system provides lessons 14 years on. BMJ 331:234-235.~
162  III,    10.  1.  3    |            children. J Public Health 14(2):71-75.~Wagner N, Meusel
163  III,    10.  2.  1    |         their mouth approximately 11-14 hours per day (ENSP, 2003).~ ~
164  III,    10.  2.  1    |           2003). Annals of Oncology; 14: 9731005. Available at: htt ~ ~
165  III,    10.  2.  1    |              Some 53 million adults (14% of the adult population
166  III,    10.  2.  1    |   effectiveness - Main report (PHIAC 14.3a). Available at: htt ~ ~
167  III,    10.  2.  1    |        Journal of Public Health Vol. 14(2):103-109.~ ~Greyling T
168  III,    10.  2.  1    |            Journal of Public Health, 14(1):110.~ ~Sobal J, Stunkard
169  III,    10.  2.  1    |          measured weight and height, 14.1% of Cypriot (Savva et
170  III,    10.  2.  1    |      Enghardt-Barbieri, 2004) and of 14.5% in the Netherlands (2-
171  III,    10.  2.  1    |     Czech Republic (9.0%, both sexes 14-17 years old) (Lobstein
172  III,    10.  2.  1    |             boys (17.0%) than girls (14.3%) being overweight. The
173  III,    10.  2.  1    |    overweight in adolescents aged 13-14 more than doubled from 1985
174  III,    10.  2.  1    |                Council Resolution of 14 December 2000 on health
175  III,    10.  2.  1    |             Obesity (Silver Spring): 14:2054-2063.~ ~Wang Y, Lobstein
176  III,    10.  2.  4    |          journal paper which covered 14.000 cases and 3000 shared
177  III,    10.  2.  4    |     Genome-wide association study of 14,000 cases of seven common
178  III,    10.  3.  1    |              million children (age 0-14) per year. Whether changes
179  III,    10.  3.  2    |           increased by an average of 14% a year between 2000 and
180  III,    10.  3.  2    |         released into water bodies (-14.5%), the various types of
181  III,    10.  3.  2    |              public health problems. 14 of the 16 European companies
182  III,    10.  3.  3    |             a mean survival of about 14 months. The main suspected
183  III,    10.  3.  4    |           the Upper Danube and up to 14% for the Meuse catchment.
184  III,    10.  4.  1    |      substantial risk to health. For 14% of people, the European
185  III,    10.  4.  1    |            Berlin, Copenhagen, Rome, 14 April 2005.~ ~WHO (2005):
186  III,    10.  4.  2    |           agents (see also Section 4.14.2).~ ~Apart from Regulation
187  III,    10.  4.  2    |     tolerable weekly intake (TWI) of 14 pg WHO-TEQ/kg body weight
188  III,    10.  4.  2    |            applied increased by only 14% and 25% respectively during
189  III,    10.  4.  2(37)|             and vegetables (OJ L 350,14.12.1986, p 71).~
190  III,    10.  4.  2    |           end, consumption data from 14 MS, 41 diet sets for different
191  III,    10.  4.  2    |            and requirements (Article 14 to 21), already existing
192  III,    10.  4.  2    |      European Communities No. L 043, 14 February 1997. Available
193  III,    10.  4.  2    |        European Communities No. L 83/14, 22 March 2006.~Available
194  III,    10.  4.  2    |             Official Journal L 350 , 14/12/1990. Available at:~htt ~ ~
195  III,    10.  4.  2    |           methods and approaches13-14 July 2006. 155.~ ~EFSA (
196  III,    10.  4.  2    | micro-organisms in food and feed. 13-14 December 2004. pp. 142.
197  III,    10.  4.  3    |              000 children aged under 14 years die annually due to
198  III,    10.  4.  5    |              On average, this equals 14 tonnes/capita but there
199  III,    10.  4.  5    |         Estonia military sites cover 14 % of the total investigated
200  III,    10.  5.  2    |      prevalence was higher in urban (14.2%) than in rural settings (
201  III,    10.  5.  3    |             by absence. E.g. whereas 14% of women working in agriculture
202  III,    10.  5.  3    |             those working part-time. 14.5% of them hold a contract
203  III,    10.  5.  3    |       economic sectors (table 10.5.3.14). Especially employees working
204  III,    10.  5.  3    |           per gender.~ ~Table 10.5.3.14. Physical risks factors
205  III,    10.  5.  3    |         relating to machinery~- 2000/14/EC: approximation of the
206  III,    10.  6.  1    |       Possible score range from 3 to 14. Scores 3-8 are considered
207  III,    10.  6.  1    |         social support and scores 12-14 strong social support.~ ~
208  III,    10.  6.  1    |              11 EU Member States and 14 EU countries participated
209   IV,    11.  1.  2(1) |          Health Accounts in 2006 for 14 OECD countries. More information
210   IV,    11.  1.  6    |          payments for immunization), 14% by fee-for-service for
211   IV,    11.  5.  3    |             Figures from 11.11 to 11.14.~ ~Figure 11.11. Organ Procurement
212   IV,    11.  5.  3    |         European countries~Figure 11.14. Percentage and absolute
213   IV,    11.  6.  2    |          inpatient stays longer than 14 days in Germany or 28 days
214   IV,    11.  6.  4    |            insurance funds (Table 11.14), the resources generated
215   IV,    11.  6.  4    |              et al 2007).~ ~Table 11.14. Collection and allocation
216   IV,    11.  6.  4    |           fund allocates~*~ ~Denmark~14 counties and the State~Each
217   IV,    11.  6.  4    |         State allocates to counties.~14 regional councils~Age, children
218   IV,    11.  6.  5    |         Academy of Management Review 14 ,(4): 57-74.~ ~Epstein AM,
219   IV,    11.  6.  5    |          Canadian Journal on Aging . 14(2): 360-390.~ ~Figueras
220   IV,    11.  6.  5    |            and Safety in Health Care 14(1): 4-5.~ ~Marshall MN,
221   IV,    12.  3        |             the EU and covering some 14.5 million employees;~· public